Shilajit: Gummies vs Capsules vs Resin — Which Form Has the Evidence?

The three forms — what each is, in plain English

What the clinical trials actually used

I went back through every Shilajit RCT I cited in our [Shilajit Evidence Scorecard](/herbs/shilajit-evidence-scorecard) and checked the methods section for delivery form.

This is not the same as saying gummies don't work — it is saying the published evidence base does not include them. A consumer buying Shilajit gummies is buying ahead of the trial evidence, even more than a consumer buying capsules is.

Active content per serving — the math comparison

This is the most useful section for a reader trying to choose.

The math reveals what the marketing usually obscures: a single gummy typically delivers a fraction of the active content of a single capsule. A "shilajit gummy" branded for daily use may need 3–5 gummies to approximate trial-equivalent dosing.

Bioavailability — what the research says about form

There is essentially no head-to-head pharmacokinetic study comparing Shilajit absorption across the three forms in humans. Most pharmacokinetic data is on standardised extract, which is the basis of capsule formulations.

In principle: - Resin dissolved in warm water has fast solubility and rapid absorption - Capsules dissolve in stomach acid and release powder for absorption (slightly slower onset) - Gummies undergo additional digestion of the gelatin/pectin matrix before extract release (likely slowest onset)

These are theoretical inferences from food-science principles, not measured data. A reader who needs precise pharmacokinetic comparison won't find it in the published literature for Shilajit specifically.

Cost per active dose — the honest comparison

This is the calculation that should drive purchase decisions but rarely does.

The pattern: gummies are not the cheapest form per active dose. They are the most expensive form after premium resin, despite being marketed as accessible and consumer-friendly. The gummy premium goes into the candy-like delivery format, not into more Shilajit.

What's actually in a Shilajit gummy

I read the ingredient list of three popular Indian Shilajit gummy brands. The typical composition (per 5 g gummy):

- 100-200 mg Shilajit extract - 2-3 g sugar or sugar alcohol (sorbitol, maltitol) - 1-1.5 g gelatin or pectin - Citric acid, natural flavouring, food colour - Sometimes added vitamins (B12, zinc) for marketing positioning

Two of the three brands I checked added sugar amounts that made each gummy roughly equivalent to a small candy. The third used sugar alcohols to position as "low sugar" — but sugar alcohols can cause GI symptoms at higher doses.

The honest implication: a Shilajit gummy is, structurally, a candy with a small amount of Shilajit. That is not necessarily bad if compliance is the main barrier — a person who would otherwise not take Shilajit at all may take a gummy. But it is meaningfully different from the standardised extract capsules the trials used.

The "easier to take" question — does compliance matter?

This is the strongest argument for gummies, and it deserves a fair hearing.

Behavioural research consistently shows that supplement compliance is a real problem. People buy supplements and stop taking them within weeks. Anything that makes a supplement easier to take consistently — better-tasting, easier to remember, more enjoyable — has a real adherence advantage.

If the choice is between taking a gummy daily for three months and taking a capsule sporadically for two weeks, the gummy may deliver more cumulative active dose despite the lower per-serving content.

What this argument doesn't address: the cost premium for gummies often exceeds the compliance benefit, and the added sugars in many gummy formulations introduce their own health considerations.

Form recommendations by use case

Three concrete scenarios.

There is no universally "best" form. The right form depends on what you're optimising for.

Why most Indian brands now offer all three forms

Walk into any Indian online supplement store and the major Shilajit brands (Kapiva, Dabur, Wellbeing Nutrition, Setu) all offer multiple formats. This isn't a coincidence — it reflects the same product diversification strategy that pharmaceutical brands use to address different consumer preferences.

The brand isn't claiming that all three forms are equivalent. It's offering different consumers different ways to engage with the product. A premium-positioned brand may offer resin (premium tier), capsules (mid tier), and gummies (entry tier) at different price points, with the per-active-dose cost generally inverse to perceived accessibility.

This is reasonable business strategy. It is also a reason consumers should not assume that their preferred-form purchase delivers the same active content as a different-form alternative.

What I would buy if I had to buy one

Reader's reasonable question. My honest answer: I would buy a standardised capsule from a brand that publishes a heavy-metal Certificate of Analysis, because that combination matches the clinical trial inputs most closely while offering quality verification.

I would not buy a gummy unless compliance was the dominant constraint, because the cost-per-active-dose is poor and the added sugars defeat much of the wellness positioning.

I would buy resin only if I could verify the brand's purity testing and was willing to pay the price premium for the most traditional preparation.

This is how I would think about the choice. It is not medical advice, and your priorities may be different from mine.

What the gummy boom says about wellness marketing

The Shilajit gummy category barely existed in India three years ago. As of April 2026, every major wave-three Indian supplement brand offers Shilajit gummies. This is worth a paragraph because the trajectory tells you something about how the wellness market actually works.

Gummies are the format pharmaceutical and supplement industries reach for when they want to broaden the consumer base beyond pill-takers. Children's vitamins are the canonical example. The format succeeds because it converts taking a supplement from a chore into a treat — a real behavioural advantage for compliance.

Applied to Shilajit, gummies do something else. They take a traditional preparation that classical Ayurveda described as a serious rasayana requiring careful preparation and turn it into a candy-format consumer product. Whether you find this democratising (more accessible to more people) or trivialising (loss of traditional preparation seriousness) depends on your starting frame.

The honest commercial framing: gummies expanded the Shilajit consumer base substantially over the past three years, particularly among younger urban Indian consumers who would not have bought a capsule or resin product. That is meaningful business growth. It is also a different consumer engagement than the traditional or research-based approaches.

What the resin form actually requires of a consumer

Most consumers who hear "buy Shilajit resin instead of capsules" don't realise what daily resin use actually requires. Let me walk through it.

You receive a glass jar with a dark, sticky tar-like substance. Each daily serving requires you to scoop a pea-sized portion (~300-500 mg) using a small spoon or applicator — the resin sticks to surfaces and is hard to dose precisely. You then dissolve this portion in warm water, milk, or ghee and consume.

The taste is challenging. Bitter, astringent, mineral — closer to tar than to herbal tea. Most first-time users describe it as unpleasant. Long-term users acclimate but it remains a notable taste experience.

The portability is poor. A resin jar is heavier and messier than a capsule bottle. Travel use is difficult. Refrigeration is sometimes recommended.

The shelf-life is variable. Resin can absorb moisture, get harder or softer with temperature changes, and become harder to dose over time.

These practical considerations explain why capsules dominate the Indian Shilajit market despite resin being closer to traditional preparation. The form factor that matches the trial input is also the easiest to use consistently — a convergence that most consumer purchase decisions reflect.

A quick comparison of three Indian gummy brands

I checked three of the most-marketed Indian Shilajit gummy brands in April 2026 to see how they actually compare.

The patterns: Shilajit content per gummy is uniformly low (100-150 mg vs 250-500 mg in capsules). Sugar content varies but is meaningful in most regular variants. Per-gummy cost ranges from Rs 12-22, which translates to Rs 25-65 daily for 2-3 gummies — substantially higher than capsule alternatives.

If gummies are the only format that fits your routine, this is the realistic cost structure to plan around.

What I would actually do — three reader scenarios

Let me make this very concrete with three reader scenarios.

There is no universally right answer. The format choice should follow your priorities and constraints, not the brand marketing hierarchy.

What's worth tracking over the next year

If you want to monitor how this question evolves, three things would meaningfully change the picture.

A pharmacokinetic study comparing Shilajit absorption across resin, capsule, and gummy delivery in matched subjects. None has been published. This would replace theoretical inferences with measured data.

A successful gummy formulation that delivers trial-equivalent Shilajit doses per serving (250+ mg) at competitive pricing. Currently, gummies undercut capsules on dose and overshoot them on cost.

Independent batch testing of gummy products for active content vs label claim. The supplement-industry general pattern is that gummies often underdeliver on label claims due to manufacturing complexity. This would be useful Indian-market specific data.

I revisit this guide every six months. Bookmark it if you want to track how Shilajit form preferences shift.

What three years of consumer-facing supplement work have taught me about form choice

This is observational rather than evidentiary, but I think it's the most useful framing for making this decision.

Most consumers overweight form choice and underweight ingredient quality. They spend more time deciding "should I get capsule or gummy?" than they spend asking "is the underlying Shilajit standardised, tested, and from a brand with reasonable disclosure?" The form question is downstream of the quality question, and quality matters more for actual outcomes.

A high-quality Shilajit in any form is generally preferable to a poorly-sourced Shilajit in your favourite form. The Upakarma resin disclosure quality matters more than the resin format itself. The Carbamide Forte branded-extract capsule matters more than the capsule format itself. The form is the delivery vehicle; the quality determines what you're actually delivering.

This isn't a deflection from the form question. It's a re-prioritisation: pick the brand based on quality, then pick the form within that brand's offerings based on your practical preferences. That order tends to produce better outcomes than picking the form first and accepting whatever quality falls out.

A final practical thought on Shilajit form choice

The form choice for Shilajit is one of those consumer decisions where the optimal answer changes with the specific person, the specific reason for use, and the specific brand quality available. There is no abstract right answer that applies universally.

What I would suggest instead: pick a brand based on disclosure quality (heavy-metal CoA, fulvic acid percentage), then pick the form within that brand's offerings based on your practical preferences. A high-disclosure brand offering capsule, resin, and gummy variants is generally a more defensible choice than a low-disclosure brand in your preferred form. Quality of source matters more than format of delivery for actual outcomes.

This framing puts the decision in the right order. Most consumers who follow it end up with better products than consumers who let format preference drive the brand choice.

Frequently asked questions

Related reads on HerbVerdict